Hypertrichosis of the eyelashes caused by bimatoprost

J Am Acad Dermatol. 2004 Nov;51(5 Suppl):S149-50. doi: 10.1016/j.jaad.2004.05.002.


The phenyl-substituted analog of prostaglandin F 2alpha , latanoprost (Xalatan; Pfizer, Inc, New York, NY) is an intraocular pressure (IOP)-lowering drug for use in patients with glaucoma and ocular hypertension. Latanoprost has been shown to stimulate eyelash hypertrichosis and has recently been proposed as a possible treatment for alopecia areata involving the eyelashes. We report a case of hypertrichosis of the eyelashes caused by the prostamide bimatoprost (Lumigan; Allergan, Inc, Irvine, Calif), a new IOP-lowering drug.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Amides
  • Antihypertensive Agents / adverse effects*
  • Bimatoprost
  • Cloprostenol / analogs & derivatives
  • Eyelashes*
  • Female
  • Glaucoma, Open-Angle / drug therapy
  • Humans
  • Hypertrichosis / chemically induced*
  • Lipids / adverse effects*


  • Amides
  • Antihypertensive Agents
  • Lipids
  • Cloprostenol
  • Bimatoprost